Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) Shares outstanding
Avantor, Inc.'s shares outstanding at the end of fiscal 2025 was $680.6M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $680.9M. Over the past ten years it has ranged from $132.7M (fiscal 2018) to $681.9M (fiscal 2024); the current reading is higher than 90% of that period. Avantor, Inc. ranks 2nd of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $680.6M | (0.19%) |
| FY2024 | $681.9M | 0.52% |
| FY2023 | $678.4M | (0.15%) |
| FY2022 | $679.4M | 13.31% |
| FY2021 | $599.6M | 2.78% |
| FY2020 | $583.4M | 45.41% |
| FY2019 | $401.2M | 202.34% |
| FY2018 | $132.7M | (12.18%) |
| FY2017 | $151.1M | (71.70%) |
| FY2016 | $534.0M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $680.9M | 0.55% |
| Jun 2026 | $677.2M | 0.06% |
| Mar 2026 | $676.8M | (0.56%) |
| Dec 2025 | $680.6M | (0.16%) |
| 29 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. | $680.9M |
| BAX Baxter International Inc. compare | $520.0M |
| BLCO Bausch + Lomb Corporation compare | $361.5M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $170.8M |
| ALGN Align Technology, Inc. compare | $71.0M |
| ATR AptarGroup, Inc. compare | $64.1M |
| RGEN Repligen Corporation compare | $56.6M |
| TFX Teleflex Incorporated compare | $43.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on AVTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement